ATIM-05. A PHASE I STUDY TARGETING NEWLY DIAGNOSED GLIOBLASTOMA WITH ANTI-CD3 × ANTI-EGFR BISPECIFIC ANTIBODY ARMED T CELLS (EGFR BATS) IN COMBINATION WITH RADIATION AND TEMOZOLOMIDE

Authors: Camilo Fadul, Jungeun Kim, Archana Thakur, Benjamin Purow, Maria-Beatriz Lopes, David Schiff, Jessica Kassay-McAllister, Joseph Donahue, Qin Liu, Lawrence Lum

Published: 2019-11-11

DOI: 10.1093/neuonc/noz175.005

Source: Full article

ATIM-05. A PHASE I STUDY TARGETING NEWLY DIAGNOSED GLIOBLASTOMA WITH ANTI-CD3 × ANTI-EGFR BISPECIFIC ANTIBODY ARMED T CELLS (EGFR BATS) IN COMBINATION WITH RADIATION AND TEMOZOLOMIDE

Abstract